RE:RE:RE:RexallYes, but you need to factor in Covid revenue.
$3 million last quarter and likely $4-5 million this quarter (Monday May 17) goes a long way to offsetting any financiing needed. If we didn't have the say the nearly $10 million from Covid so far that would have been 2 more rounds of financing. What would that have done to the market cap?
The last financing was approx 9 million shares for $7 million. Without Covid we would have likely given up 15-20 million shares or more. That's 20-30% of the outstanding and would have had a much larger impact on market cap.
StevenBirch wrote: Or $0.72 anyway. Look I want it to go up as much as the next guy but this is not a covid stock. Covid testing while important is not the future and not where the money is even though it may add some revenue now. This stock is not at this level because we didn't get the Rexall announcement a month ago, it got halved because of an incoherent Aristotle message.
Some are trying to remain positive but others are either close to or outright pumpers. I say check the ones who attack anyone who even questions the near term outlook for this stock because the market seems to be backing those people right now.
Thisguyiscool wrote: Hitting $1 today